CAROLINA

The CAROLINA trial assessed the long-term CV safety of linagliptin in patients with relatively early T2D at increased CV risk. This module details the results.

CAROLINA
Rate this content
  • CAROLINA
  • Contents
  • Contents
  • A historical perspective: What was the DPP-4 inhibitor CVOT landscape when CAROLINA started?
  • SUs and DPP-4 inhibitors continue to be widely used add-on glucose-lowering agents
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go